Research Papers:

The LPA1/ZEB1/miR-21-activation pathway regulates metastasis in basal breast cancer

Debashish Sahay, Raphael Leblanc, Thomas G.P. Grunewald, Srikant Ambatipudi, Johnny Ribeiro, Philippe Clézardin and Olivier Peyruchaud _

PDF  |  HTML  |  Supplementary Files  |  How to cite

Oncotarget. 2015; 6:20604-20620. https://doi.org/10.18632/oncotarget.3774

Metrics: PDF 1744 views  |   HTML 2757 views  |   ?  


Debashish Sahay1, Raphael Leblanc1, Thomas G. P. Grunewald2, Srikant Ambatipudi3, Johnny Ribeiro1, Philippe Clézardin1, Olivier Peyruchaud1

1INSERM, UMR1033, UCB Lyon 1, Faculté de Médecine Lyon Est, Lyon, France

2Laboratory for Pediatric Sarcoma Biology, Institute of Pathology, LMU Munich, Munich, Germany

3Epigenetics Group, International Agency for Research on Cancer, Lyon, France

Correspondence to:

Olivier Peyruchaud, e-mail: [email protected]

Keywords: lysophosphatidic acid, ZEB1, miR-21, breast cancer, metastasis

Received: March 03, 2015     Accepted: April 15, 2015     Published: April 27, 2015


Lysophosphatidic acid (LPA) is a bioactive lipid promoting cancer metastasis. LPA activates a series of six G protein-coupled receptors (LPA1-6). While blockage of LPA1 in vivo inhibits breast carcinoma metastasis, down-stream genes mediating LPA-induced metastasis have not been yet identified. Herein we showed by analyzing publicly available expression data from 1488 human primary breast tumors that the gene encoding the transcription factor ZEB1 was the most correlated with LPAR1 encoding LPA1. This correlation was most prominent in basal primary breast carcinomas and restricted to cell lines of basal subtypes. Functional experiments in three different basal cell lines revealed that LPA-induced ZEB1 expression was regulated by the LPA1/Phosphatidylinositol-3-Kinase (Pi3K) axis. DNA microarray and real-time PCR analyses further demonstrated that LPA up-regulated the oncomiR miR-21 through an LPA1/Pi3K/ZEB1-dependent mechanism. Strikingly, treatment with a mirVana miR-21 inhibitor, or silencing LPA1 or ZEB1 completely blocked LPA-induced cell migration in vitro, invasion and tumor cell bone colonization in vivo, which can be restored with a mirVana miR-21 mimic. Finally, high LPAR1 expression in basal breast tumors predicted worse lung-metastasis-free survival. Collectively, our results elucidate a new molecular pathway driving LPA-induced metastasis, thus underscoring the therapeutic potential of targeting LPA1 in patients with basal breast carcinomas.

Creative Commons License All site content, except where otherwise noted, is licensed under a Creative Commons Attribution 3.0 License.
PII: 3774